_id
691b108e3c536f8df2318a79
Ticker
ALQGC.PA
Name
Quantum Genomics SA
Exchange
PA
Address
6, rue Cambacérès, Paris, France, 75008
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://quantum-genomics.com
Description
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Last Close
0.0721
Volume
-
Current Price
0.0721
Change
0
Last Updated
2025-11-27T11:40:46.090Z
Image
https://logo.clearbit.com/quantum-genomics.com
Ipo Date
-
Market Cap
5026087
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
0
Cost Of Revenue
250960
Gross Profit
-250960
Operating Expenses
-
Operating Income
-355560
Interest Expense
-
Pretax Income
-676980
Net Income
-676980
Eps
-0.009711382664884999
Dividends Per Share
-
Shares Outstanding
69709954
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
301020
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
353100
Property Plant Equipment
1048
Total Assets
354650
Payables
145407
Short Term Debt
507800
Long Term Debt
2130840
Total Liabilities
2810590
Equity
-2455940
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
PE
-
PB
-2.0465025183839995
ROE
27.56500565974739
ROA
-190.88678979275343
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
250960
Quarters > 0 > income Statement > gross Profit
-250960
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-355560
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-676980
Quarters > 0 > income Statement > net Income
-676980
Quarters > 0 > income Statement > eps
-0.009711382664884999
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
69709950
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
301020
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
353100
Quarters > 0 > balance Sheet > property Plant Equipment
1048
Quarters > 0 > balance Sheet > total Assets
354650
Quarters > 0 > balance Sheet > payables
145407
Quarters > 0 > balance Sheet > short Term Debt
507800
Quarters > 0 > balance Sheet > long Term Debt
2130840
Quarters > 0 > balance Sheet > total Liabilities
2810590
Quarters > 0 > balance Sheet > equity
-2455940
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
-0.009711382664884999
Quarters > 0 > ratios > PB
-2.0465025183839995
Quarters > 0 > ratios > ROE
27.56500565974739
Quarters > 0 > ratios > ROA
-190.88678979275343
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
2056
Quarters > 1 > income Statement > cost Of Revenue
2056
Quarters > 1 > income Statement > gross Profit
-894350
Quarters > 1 > income Statement > operating Expenses
1119876
Quarters > 1 > income Statement > operating Income
-1122000
Quarters > 1 > income Statement > interest Expense
7072000
Quarters > 1 > income Statement > pretax Income
-8216000
Quarters > 1 > income Statement > net Income
-8216000
Quarters > 1 > income Statement > eps
-0.2357054647921847
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
34857062
Quarters > 1 > income Statement > income Tax Expense
-8216000
Quarters > 1 > income Statement > EBITDA
-8204036
Quarters > 1 > income Statement > operating Margin
-54571.98443579766
Quarters > 1 > income Statement > total Other Income Expense Net
-7094000
Quarters > 1 > balance Sheet > cash
704154
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
103996
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
840676
Quarters > 1 > balance Sheet > property Plant Equipment
1589
Quarters > 1 > balance Sheet > total Assets
891684
Quarters > 1 > balance Sheet > payables
236490
Quarters > 1 > balance Sheet > short Term Debt
683202
Quarters > 1 > balance Sheet > long Term Debt
1693763
Quarters > 1 > balance Sheet > total Liabilities
2670648
Quarters > 1 > balance Sheet > equity
-1778964
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
-22000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > ratios > PE
-0.2357054647921847
Quarters > 1 > ratios > PB
-1.4127290772606977
Quarters > 1 > ratios > ROE
461.8418360349057
Quarters > 1 > ratios > ROA
-921.402649369059
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
12
Quarters > 2 > income Statement > cost Of Revenue
539727
Quarters > 2 > income Statement > gross Profit
-539715
Quarters > 2 > income Statement > operating Expenses
606340
Quarters > 2 > income Statement > operating Income
-1146055
Quarters > 2 > income Statement > interest Expense
7676
Quarters > 2 > income Statement > pretax Income
-1219779
Quarters > 2 > income Statement > net Income
-1185348
Quarters > 2 > income Statement > eps
-0.034003934061144304
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
34859143
Quarters > 2 > income Statement > income Tax Expense
-34431
Quarters > 2 > income Statement > EBITDA
-886759
Quarters > 2 > income Statement > operating Margin
-9550458.333333332
Quarters > 2 > income Statement > total Other Income Expense Net
-73724
Quarters > 2 > balance Sheet > cash
3547387
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
119177
Quarters > 2 > balance Sheet > inventories
-119176
Quarters > 2 > balance Sheet > total Current Assets
3687249
Quarters > 2 > balance Sheet > property Plant Equipment
7887
Quarters > 2 > balance Sheet > total Assets
3746771
Quarters > 2 > balance Sheet > payables
272217
Quarters > 2 > balance Sheet > short Term Debt
756510
Quarters > 2 > balance Sheet > long Term Debt
1960330
Quarters > 2 > balance Sheet > total Liabilities
3310107
Quarters > 2 > balance Sheet > equity
436664
Quarters > 2 > cash Flow > net Income
-1185348
Quarters > 2 > cash Flow > depreciation
259297
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-2753017
Quarters > 2 > ratios > PE
-0.034003934061144304
Quarters > 2 > ratios > PB
5.75578524975725
Quarters > 2 > ratios > ROE
-271.45539820090505
Quarters > 2 > ratios > ROA
-31.636521153814844
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
19
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
10060
Quarters > 3 > income Statement > cost Of Revenue
1946701
Quarters > 3 > income Statement > gross Profit
-1936641
Quarters > 3 > income Statement > operating Expenses
63913
Quarters > 3 > income Statement > operating Income
-2000550
Quarters > 3 > income Statement > interest Expense
13725
Quarters > 3 > income Statement > pretax Income
-1985599
Quarters > 3 > income Statement > net Income
-1985599
Quarters > 3 > income Statement > eps
-0.05757764496932327
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
34485589
Quarters > 3 > income Statement > income Tax Expense
4
Quarters > 3 > income Statement > EBITDA
-1986721
Quarters > 3 > income Statement > operating Margin
-19886.182902584493
Quarters > 3 > income Statement > total Other Income Expense Net
14951
Quarters > 3 > balance Sheet > cash
2758196
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2839405
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5640357
Quarters > 3 > balance Sheet > property Plant Equipment
19496
Quarters > 3 > balance Sheet > total Assets
5755413
Quarters > 3 > balance Sheet > payables
545660
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
2908910
Quarters > 3 > balance Sheet > total Liabilities
4132251
Quarters > 3 > balance Sheet > equity
1623162
Quarters > 3 > cash Flow > net Income
-1985599
Quarters > 3 > cash Flow > depreciation
4476
Quarters > 3 > cash Flow > change In Working Capital
9829066
Quarters > 3 > cash Flow > cash From Operations
-7638936
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-6811
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-7645747
Quarters > 3 > ratios > PE
-0.05757764496932327
Quarters > 3 > ratios > PB
1.5318316760126223
Quarters > 3 > ratios > ROE
-122.32907128185605
Quarters > 3 > ratios > ROA
-34.49967882409134
Quarters > 3 > ratios > FCF
-7638936
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-759.3375745526839
Quarters > 3 > health Score
20
Valuation > metrics > PE
-0.009711382664884999
Valuation > metrics > PB
-2.0465025183839995
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
27.56500565974739
Profitability > metrics > ROA
-191.7247238742566
Profitability > final Score
55
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5405637110441254
Liquidity > metrics > Quick Ratio
0.5405637110441254
Liquidity > final Score
37
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
22.4421475024275
Prev Valuations > 2
80
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
29
Prev Risks > 1
-591
Prev Risks > 2
-565
Prev Liquidities > 0
56
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:09:13.732Z
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Quantum Genomics SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2024-12-31)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.